You could qualify for the GRADUATE clinical study – a clinical study that will assess how safe and effective an investigational drug may be at slowing the progression of early or mild Alzheimer’s disease – if you:
are 50-90 years old
have mild Alzheimer’s disease or memory problems that may be the early symptoms of the condition
If these things are true, you could qualify. The GRADUATE study is sponsored by Genentech, a wholly owned member of the Roche Group.